Guo-Wang Yang
Overview
Explore the profile of Guo-Wang Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng C, Liu Q, Yang M, Cui H, Ge Y, Li Q, et al.
Chin Med
. 2024 Nov;
19(1):153.
PMID: 39497116
Background: Irinotecan is a standard chemotherapeutic agent in small cell lung cancer (SCLC), however, as a common adverse reaction, diarrhea limits the use of irinotecan. Shengjiang Xiexin decoction (SXD) has...
2.
Yang G, Zhuang M, Shi H, Song X, Liu H, Ji F, et al.
Heliyon
. 2024 Sep;
10(16):e36186.
PMID: 39253220
Background: Multimodal analgesia plays a key role in enhanced recovery after surgery. Herein, we describe a trial protocol investigating the effects of oxycodone-vs. sufentanil-based patient-controlled analgesia in combination with quadratus...
3.
Zeng Y, Zhang G, Guo J, Yang M, Han Q, Yang G
Zhonghua Nan Ke Xue
. 2024 Aug;
30(7):588-596.
PMID: 39212392
Objective: To evaluate the potential causal relationship between inflammatory factors and PCa using the two-sample Mendelian randomization (MR) method. Methods: We selected summary statistics of genome-wide association studies (GWAS) (n...
4.
Yang G, Cheng H, Song X, Yang Y, Liu H, Ji F, et al.
Drug Des Devel Ther
. 2024 Jun;
18:1799-1810.
PMID: 38828025
Purpose: Oxycodone is a potent μ- and κ-opioid receptor agonist that can relieve both somatic and visceral pain. We assessed oxycodone- vs sufentanil-based multimodal analgesia on postoperative pain following major...
5.
Wu T, Chen Y, Yuan Z, Yang G, Zhang G
BMC Complement Med Ther
. 2024 Mar;
24(1):125.
PMID: 38500118
Background: Osimertinib is regarded as a promising third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) for advanced non-squamous non-small cell lung cancer (NSCLC) patients who developed T790M. However...
6.
Ma Y, Li G, Sun X, Li X, Gao Y, Gao C, et al.
Am J Transl Res
. 2021 Oct;
13(9):10163-10177.
PMID: 34650688
FAM107A may have a dual role in regulating the biological functions of tumors; however, its role in prostate adenocarcinoma (PRAD) remains unknown. We analyzed FAM107A expression by employing databases to...
7.
Yang W, Zhang G, Cao K, Yang G
Biomed Res Int
. 2021 Sep;
2021:5473959.
PMID: 34485514
Background: The hypercoagulable status, which forms a vicious cycle with hematogenous metastasis, is a common systemic alteration in cancers. As modeling is a key approach in research, a model which...
8.
Yang W, Shi L, Wang X, Yang G
Aging (Albany NY)
. 2021 Aug;
13(16):20836-20852.
PMID: 34461608
Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates a variety of biological processes that promote tumor progression. In this study, we analyzed the correlation between HPSE expression and prognosis...
9.
Lin Y, Yang W, Yang G
Aging (Albany NY)
. 2021 May;
13(9):12929-12954.
PMID: 33952716
Liver hepatocellular carcinoma (LIHC) remains one of the most common causes of cancer death. Prior research suggested that the PPM1G gene is involved in LIHC. To explore the role of...
10.
Li Q, Zhang G, Hao C, Ma Y, Sun X, Zhang Y, et al.
J Ethnopharmacol
. 2020 Oct;
266:113430.
PMID: 33011366
Ethnopharmacological Relevance: Astragalus mongholicus, Solanum nigrum Linn, Lotus plumule, Ligusticum are widely used traditional herbal medicines for cancer treatment in China. They were typical drugs selected from Gubenyiliu II and...